Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Wilson, Kevin | Person |
Why?
|
| Lafyatis, Robert | Person |
Why?
|
| 2018 Clinical Practice Guideline Summary for Clinicians: Diagnosis of Idiopathic Pulmonary Fibrosis. | Academic Article |
Why?
|
| A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. | Academic Article |
Why?
|
| A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities. | Academic Article |
Why?
|
| Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis. | Academic Article |
Why?
|
| C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis. | Academic Article |
Why?
|
| Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies. | Academic Article |
Why?
|
| Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis. | Academic Article |
Why?
|
| Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis. | Academic Article |
Why?
|
| End-Stage Idiopathic Pulmonary Fibrosis Lung Microenvironment Promotes Impaired NK Activity. | Academic Article |
Why?
|
| Gastroesophageal reflux disease and idiopathic pulmonary fibrosis. | Academic Article |
Why?
|
| GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis. | Academic Article |
Why?
|
| Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. | Academic Article |
Why?
|
| Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. | Academic Article |
Why?
|